Literature DB >> 19659831

Panax notoginseng saponins attenuate acute lung injury induced by intestinal ischaemia/reperfusion in rats.

Ling Rong1, Yuqing Chen, Mudan He, Xin Zhou.   

Abstract

BACKGROUND AND
OBJECTIVE: Acute lung injury remains a challenge for both clinicians and scientists. The effects of Panax notoginseng saponins (PNS) on acute lung injury induced by intestinal ischaemia/reperfusion (II/R) were studied in rats.
METHODS: Forty-eight Wistar rats were randomly assigned to four groups: (1) a sham-operated group that received laparotomy without II/R (n= 12); (2) a sham + PNS group, which was identical to group 1 except for PNS treatment (n= 12); (3) an II/R group that had 1 h of intestinal ischaemia followed by 3 h of reperfusion (n= 12); and (4) an II/R + PNS group that received 100 mg/kg of PNS, i.v., 15 min before reperfusion (n= 12). The effects of PNS administration on lung tissue histology, activities of oxidant and antioxidant enzymes, levels of malondialdehyde, nitric oxide and inducible nitric oxide synthase activity were examined. Levels of surfactant protein B, cell numbers in BAL fluid and plasma levels of pro-inflammatory cytokines were also examined.
RESULTS: Compared with the II/R group, pulmonary parenchymal damage, activities of oxidant enzymes, levels of malondialdehyde and nitric oxide, inducible nitric oxide synthase activity in lung tissue, and plasma levels of pro-inflammatory cytokines were significantly reduced by PNS treatment. In addition, the decreases in antioxidant enzyme activities were prevented in the II/R + PNS group. Total leukocyte and neutrophil counts were significantly decreased by PNS treatment. The decline in surfactant protein B levels in BAL fluid was reduced in the II/R + PNS group compared with the II/R group.
CONCLUSIONS: Administration of PNS before reperfusion injury alleviates acute lung injury induced by II/R, and this is attributable to the antioxidant and anti-inflammatory effects of PNS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19659831     DOI: 10.1111/j.1440-1843.2009.01586.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  6 in total

1.  Panax notoginseng saponins protect kidney from diabetes by up-regulating silent information regulator 1 and activating antioxidant proteins in rats.

Authors:  Yue-Guang Du; Li-Pei Wang; Jun-Wen Qian; Ke-Na Zhang; Ke-Fu Chai
Journal:  Chin J Integr Med       Date:  2015-12-28       Impact factor: 1.978

2.  Panax notoginseng Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.

Authors:  Kuen-Daw Tsai; Shu-Mei Yang; Jen-Chih Lee; Ho-Yiu Wong; Chuen-Ming Shih; Ting-Hui Lin; Min-Jen Tseng; Wei Chen
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-06       Impact factor: 2.629

3.  Lymphatic muscle cells contribute to dysfunction of the synovial lymphatic system in inflammatory arthritis in mice.

Authors:  Qianqian Liang; Li Zhang; Hao Xu; Jinlong Li; Yan Chen; Edward M Schwarz; Qi Shi; Yongjun Wang; Lianping Xing
Journal:  Arthritis Res Ther       Date:  2021-02-19       Impact factor: 5.156

4.  Protective effects of the notoginsenoside R1 on acute lung injury by regulating the miR-128-2-5p/Tollip signaling pathway in rats with severe acute pancreatitis.

Authors:  Ju He; Ming-Wei Liu; Zhi-Yi Wang; Rong-Jie Shi
Journal:  Innate Immun       Date:  2022-01       Impact factor: 2.680

Review 5.  Potential effects of medicinal plants and secondary metabolites on acute lung injury.

Authors:  Daniely Cornélio Favarin; Jhony Robison de Oliveira; Carlo Jose Freire de Oliveira; Alexandre de Paula Rogerio
Journal:  Biomed Res Int       Date:  2013-10-09       Impact factor: 3.411

6.  Panax notoginseng saponins ameliorate cisplatin-induced mitochondrial injury via the HIF-1α/mitochondria/ROS pathway.

Authors:  Qingqing Li; Xueyan Liang; Yufang Yang; Xian Zeng; Xiaobin Zhong; Chun Huang
Journal:  FEBS Open Bio       Date:  2019-12-05       Impact factor: 2.693

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.